What we believe:
Trinity Partners is a global life sciences strategic consulting company. We provide the targeted information that gives our clients a vital competitive edge. We’re experts in formulating strategic insights through intensive analysis and fact-gathering. Our goal is to help our clients succeed in today’s competitive environment.
Who we’ve worked with:
We’ve developed long-term relationships with a wide range of leading pharmaceutical, biotech, medical device, and diagnostic companies. Our clients are among the most successful firms in the industry, whose global reach impacts the lives of millions of people around the world.
Why our approach is so successful:
As a strategic consulting company, our approach is designed to provide our clients with the vision and thoughtful groundwork they need for precise decision making. This includes identifying performance issues, pinpointing areas for growth, highlighting market opportunities, and answering market needs.
Parthenon Capital Partners has made an investment in Waltham, Massachusetts-based Trinity Partners, a life sciences strategy consulting firm. No financial terms were disclosed. Baird was financial adviser to Trinity on the transaction.